1 Item 1A. Risk Factors 40 Item 1B. Unresolved Staff Comments 99 Item 1C. Cybersecurity 99 Item 2. Properties 101 Item 3. Legal Proceedings 101 Item 4. Mine Safety Disclosures 101 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 102 Item 6. [Reserved] 102 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 103 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 113 ...
Q2 FY2026 — expected 2026-09-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-23 | 2025-12-31 | 0001193125-26-119770 | EDGAR | 120K words |
| 2025-03-31 | 2024-12-31 | 0000950170-25-047835 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001193125-25-280260 | EDGAR | 73K words |
| 2025-08-13 | 2025-06-30 | 0000950170-25-108116 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071560 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-24 | 0001193125-26-120164 | EDGAR | 1K words |
| 2026-03-23 | 0001193125-26-119727 | EDGAR | — |
| 2026-02-27 | 0001193125-26-082787 | EDGAR | — |
| 2026-02-12 | 0001193125-26-047757 | EDGAR | — |
| 2026-02-10 | 0001193125-26-043764 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009862 | EDGAR | — |
| 2025-12-10 | 0001193125-25-314364 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280235 | EDGAR | — |
| 2025-11-06 | 0001193125-25-267402 | EDGAR | — |
| 2025-11-04 | 0001193125-25-264748 | EDGAR | — |
26 total filings indexed. 11 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001774857 |
| Ticker | AARD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.aardvarktherapeutics.com |
| Listed | 2025-02-13 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report